| Patterns, timing, and predictors of recurrence following pancreatectomy for pancreatic ductal adenocarcinoma VP Groot, N Rezaee, W Wu, JL Cameron, EK Fishman, RH Hruban, ... Annals of surgery 267 (5), 936-945, 2018 | 514 | 2018 |
| Poorly differentiated neuroendocrine carcinomas of the pancreas: a clinicopathologic analysis of 44 cases O Basturk, L Tang, RH Hruban, V Adsay, Z Yang, AM Krasinskas, ... The American journal of surgical pathology 38 (4), 437-447, 2014 | 259 | 2014 |
| Impact total psoas volume on short-and long-term outcomes in patients undergoing curative resection for pancreatic adenocarcinoma: a new tool to assess sarcopenia N Amini, G Spolverato, R Gupta, GA Margonis, Y Kim, D Wagner, ... Journal of Gastrointestinal Surgery 19 (9), 1593-1602, 2015 | 237 | 2015 |
| The impact of postoperative complications on the administration of adjuvant therapy following pancreaticoduodenectomy for adenocarcinoma W Wu, J He, JL Cameron, M Makary, K Soares, N Ahuja, N Rezaee, ... Annals of surgical oncology 21, 2873-2881, 2014 | 199 | 2014 |
| Clinicopathological Correlates of Activating GNAS Mutations in Intraductal Papillary Mucinous Neoplasm (IPMN) of the Pancreas M Dal Molin, H Matthaei, J Wu, A Blackford, M Debeljak, N Rezaee, ... Annals of surgical oncology 20, 3802-3808, 2013 | 181 | 2013 |
| Genetic analyses of isolated high‐grade pancreatic intraepithelial neoplasia (HG‐PanIN) reveal paucity of alterations in TP53 and SMAD4 W Hosoda, P Chianchiano, JF Griffin, ME Pittman, LAA Brosens, M Noë, ... The Journal of pathology 242 (1), 16-23, 2017 | 148 | 2017 |
| Genetic And Morphological Evaluation (GAME) score for patients with colorectal liver metastases GA Margonis, K Sasaki, S Gholami, Y Kim, N Andreatos, N Rezaee, ... Journal of British Surgery 105 (9), 1210-1220, 2018 | 129 | 2018 |
| Development and validation of a multi-institutional preoperative nomogram for predicting grade of dysplasia in intraductal papillary mucinous neoplasms (IPMNs) of the pancreas … MA Attiyeh, C Fernández-del Castillo, M Al Efishat, AA Eaton, M Gönen, ... Annals of surgery 267 (1), 157-163, 2018 | 122 | 2018 |
| Targeted DNA sequencing reveals patterns of local progression in the pancreatic remnant following resection of intraductal papillary mucinous neoplasm (IPMN) of the pancreas A Pea, J Yu, N Rezaee, C Luchini, J He, M Dal Molin, JF Griffin, H Fedor, ... Annals of surgery 266 (1), 133-141, 2017 | 119 | 2017 |
| Neutrophil-to-lymphocyte ratio is a predictive marker for invasive malignancy in intraductal papillary mucinous neoplasms of the pancreas G Gemenetzis, F Bagante, JF Griffin, N Rezaee, AA Javed, LL Manos, ... Annals of surgery 266 (2), 339-345, 2017 | 117 | 2017 |
| Very long-term survival following resection for pancreatic cancer is not explained by commonly mutated genes: results of whole-exome sequencing analysis M Dal Molin, M Zhang, RF De Wilde, NA Ottenhof, N Rezaee, ... Clinical Cancer Research 21 (8), 1944-1950, 2015 | 114 | 2015 |
| Intraductal papillary mucinous neoplasm (IPMN) with high-grade dysplasia is a risk factor for the subsequent development of pancreatic ductal adenocarcinoma N Rezaee, C Barbon, A Zaki, J He, B Salman, RH Hruban, JL Cameron, ... Hpb 18 (3), 236-246, 2016 | 99 | 2016 |
| Genetic analysis of small well-differentiated pancreatic neuroendocrine tumors identifies subgroups with differing risks of liver metastases A Pea, J Yu, L Marchionni, M Noe, C Luchini, A Pulvirenti, RF De Wilde, ... Annals of surgery 271 (3), 566-573, 2020 | 89 | 2020 |
| Main duct dilatation is the best predictor of high-grade dysplasia or invasion in intraductal papillary mucinous neoplasms of the pancreas M Del Chiaro, R Beckman, Z Ateeb, N Orsini, N Rezaee, L Manos, ... Annals of surgery 272 (6), 1118-1124, 2020 | 79 | 2020 |
| Perioperative outcomes and long-term quality of life after total pancreatectomy A Pulvirenti, A Pea, N Rezaee, C Gasparini, G Malleo, MJ Weiss, ... Journal of British Surgery 106 (13), 1819-1828, 2019 | 70 | 2019 |
| Validation of histomolecular classification utilizing histological subtype, MUC1, and CDX2 for prognostication of resected ampullary adenocarcinoma A Schueneman, M Goggins, J Ensor, B Saka, N Neishaboori, S Lee, ... British journal of cancer 113 (1), 64-68, 2015 | 55 | 2015 |
| Multi-institutional validation study of pancreatic cyst fluid protein analysis for prediction of high-risk intraductal papillary mucinous neoplasms of the pancreas MA Al Efishat, MA Attiyeh, AA Eaton, M Gönen, D Prosser, AE Lokshin, ... Annals of surgery 268 (2), 340-347, 2018 | 46 | 2018 |
| Postoperative complications after resection of borderline resectable and locally advanced pancreatic cancer: The impact of neoadjuvant chemotherapy with conventional radiation … AB Blair, LM Rosati, N Rezaee, G Gemenetzis, L Zheng, RH Hruban, ... Surgery 163 (5), 1090-1096, 2018 | 44 | 2018 |
| A novel approach for selecting combination clinical markers of pathology applied to a large retrospective cohort of surgically resected pancreatic cysts DL Masica, M Dal Molin, CL Wolfgang, T Tomita, MR Ostovaneh, ... Journal of the American Medical Informatics Association 24 (1), 145-152, 2017 | 43 | 2017 |
| Immunolabeling of cleared human pancreata provides insights into three-dimensional pancreatic anatomy and pathology M Noë, N Rezaee, K Asrani, M Skaro, VP Groot, PH Wu, MT Olson, ... The American Journal of Pathology 188 (7), 1530-1535, 2018 | 42 | 2018 |
Christopher L.WolfgangNYU Grossman School of MedicineAdresă de e-mail confirmată pe NYULangone.org
